Blog Posts (18)
March 24, 2015
In the old days, blockbuster drugs were moderately expensive pills taken by hundreds of thousands of patients. Think blood pressure, cholesterol and diabetes pills. But today, many blockbusters are designed to target much less common diseases, illnesses like multiple sclerosis … Continue reading →
The post The High Price of Affordable Medicine appeared first on PeterUbel.com.
March 3, 2015
She didn’t talk like a stroke victim. “I…I…I…k…kkk…can…can…can’t…t…t…t…talk.” She struggled with her words, struggling on early syllables, only to then spurt out full and correct words. “N…N…N…No.” Recognizing this unusual speech pattern, the neurologist Allan Ropper, author of Reaching Down … Continue reading →
The post The Lost Art Of Not Ordering A CAT Scan appeared first on PeterUbel.com.
February 9, 2015
Cholesterol pills are one of the great medical advances I’ve witnessed during my professional career. I am talking specifically about a category of medications called statins, drugs like Lipitor and Pravachol. These drugs have prevented probably hundreds of thousands of … Continue reading →
The post Proven: People Don’t Take Medicare They Can’t Afford appeared first on PeterUbel.com.
February 4, 2015
Bend a resilient object and it will spring back with a vengeance once released from your grip. Is that what is about to happen to healthcare spending? For years now, experts have been debating ways to “bend the cost curve … Continue reading →
The post Is Healthcare Spending About To Accelerate? appeared first on PeterUbel.com.
January 30, 2015
A while ago, I wrote a post on how hard it can be for Medicaid recipients to get medical appointments, because so many physicians limit the number of Medicaid patients they see. They limit the number because Medicaid reimbursement is … Continue reading →
The post How Generously Does Your State Reimburse for Medicaid? appeared first on PeterUbel.com.
January 28, 2015
Two problems loom large over the American medical care system. First, we spend outrageous amounts of money on healthcare, with too many patients receiving too many services at too high a price. Second, our malpractice system is an international embarrassment, … Continue reading →
The post Malpractice Reform Won’t Save Money appeared first on PeterUbel.com.
January 27, 2015
Hepatitis C has been in the news lately, because of amazing (and amazingly expensive) new treatments that promise to cure their life-threatening illness. While we ought to debate the expense of these treatments, we should also remind ourselves of how … Continue reading →
January 5, 2015
India is not, yet, a wealthy country. Nevertheless its people experience many of the same expensive-to-treat illnesses as wealthier populations in the U.S. and Europe. Therefore the country has made a series of policy decisions designed to lower the cost … Continue reading →
October 16, 2014
Biologic drugs are a big deal for the pharmaceutical industry right now. Blockbuster chemicals for common conditions like diabetes and hypertension are largely things of the past. We’re getting pretty good at controlling those conditions, and few people expect a … Continue reading →
October 10, 2014
High costs make it hard for many patients to afford their medications. That’s why some medical experts believe we should give important medications to patients for free, to see if that improves their health outcomes. One famous example of this … Continue reading →
View More Blog Entries
June 19, 2013 3:08 pm
Unfortunately, limited by many factors, our health-care system has suffered from insufficient experimentation and a lack of innovation in approaches to physician and nonphysician provider compensation.
May 21, 2012 4:55 pm
Think of it as a health policy wonk’s dream: Football stadium after
One insurance company’s data could fill 60 million of these. (bigstockphoto) football stadium packed to the brim with…health insurance claims data. An odd dream, to be sure. But health insurance data is crucial to understand how health care dollars get spent. It shows how people use health care, what’s changing and, in some cases, why. Health insurers, however, have tended to keep that data private, as it could tip competitors off to how they handle business.
May 20, 2012 1:37 pm
Having the results of a personalized genetic test did not drive patients to utilize potentially costly follow-up healthcare services, a study from the National Institutes of Health (NIH) found. In the past five years, there have been many new tests marketed to consumers who want to know whether they are genetically susceptible to a range of health conditions and traits, including diabetes and certain types of cancers. The tests, known as multiplex assays when they test for a variety of genetic variations, are marketed by a number of for-profit companies.
May 14, 2012 10:14 am
An Irish adage says: “When you come to a wall that is too high to climb, throw your hat over the wall, and then go get your hat.” That’s what Massachusetts started with its 2006 law requiring just about everyone to get coverage and arranging to make that coverage affordable. Now, it’s time to get the hat.
April 30, 2012 10:37 am
Worried that questioning your doctor will damage your relationship or make for an awkward office visit? Time to untie your tongue. Asking a few key questions at your next appointment could save you both money and exposure to medical risks. Meanwhile, more doctors are volunteering to help the conversation along and prescribe evidence-based conservative measures first.
April 12, 2012 11:39 pm
Spurred by patients and patient advocates like Ms. Kuhn, lawmakers in at least 20 states, from Maine to Hawaii, have introduced bills that would limit out-of-pocket payments by consumers for expensive drugs used to treat diseases like cancer,rheumatoid arthritis, multiple sclerosis and inherited disorders.
April 5, 2012 12:57 pm
The national conversation about health care reform focuses relentlessly on cost reduction. While bending the cost curve is extremely important, improving quality is also essential — but sometimes downplayed — in today’s reform equation. Grappling with quality challenges has attracted a new breed of health care leaders: physician and nurse executives.